8102 J . Org. Chem., Vol. 62, No. 23, 1997
Mukai et al.
174 (M+, 1.1), 156 (17), 116 (88), 101 (26), 74 (100), 56 (82); IR
afforded (+)-34 (60.5 mg, 74%) as a colorless oil along with
(-)-26 (12.3 mg, 15%). Compound (+)-34: [R]23D +92.8 (c 0.30,
CHCl3); MS m/z 514 (M+, 0.3), 457 (44), 367 (44), 349 (57),
1
3350, 3475, 1775 cm-1; H NMR δ 4.88 (br s, 2H), 4.63, 4.28
(AB-q, 2H, J ) 10.2 Hz), 4.21-4.15 (m, 2H), 4.11 (br s, 1H),
3.81 (dt, 1H, J ) 3.3, 4.6 Hz), 2.98, 2.66 (AB-q, 2H, J ) 17.8
Hz); 13C NMR δ 178.65, 89.16, 81.58, 78.42, 75.59, 74.68, 40.64.
Anal. Calcd for C7H10O5: C, 48.28; H, 5.79. Found: C, 48.13;
H, 5.76.
1
244 (22), 129 (36), 91 (99), 57 (100),; IR 2225, 1685 cm-1; H
NMR δ 7.41-7.23 (m, 15H), 4.69, 4.60 (AB-q, 2H, J ) 11.7
Hz), 4.58, 4.45 (AB-q, 2H, J ) 11.7 Hz), 4.43 (d, 1H, J ) 2.0
Hz), 4.24 (dd, 1H, J ) 6.4, 9.8 Hz), 4.12 (ddd, 1H, J ) 2.0, 3.9,
6.4 Hz), 4.00 (dd, 1H, J ) 3.9, 9.8 Hz), 3.26, 3.14 (AB-q, 2H, J
) 15.1 Hz), 1.46 (s, 9H); 13C NMR δ 196.05, 137.81, 137.61,
131.84, 128.37, 128.32, 128.27, 128.03, 127.92, 127.85, 127.64,
127.53, 122.66, 87.87, 87.51, 86.70, 83.18, 78.94, 72.53, 71.52,
71.02, 49.18, 48.12, 29.76. Anal. Calcd for C32H34O4S: C,
74.68; H, 6.66. Found: C, 74.68; H, 6.70.
(+)-(3 R ,4 S ,5 S )-4 -(H e x a n o y l o x y )-3 -h y d r o x y -1 ,7 -
d ioxa sp ir o[4.4]n on a n -8-on e (31) [(+)-5-Ep isecosyr in 1]
a n d (-)-(3R,4S,5S)-3,4-Bis(h exa n oyloxy)-1,7-d ioxa sp ir o-
[4.4]n on a n -8-on e (32). A solution of hexanoic anhydride (0.1
M THF solution, 2.3 mL, 0.23 mmol) was added to a solution
of (+)-30 (40 mg, 0.23 mmol), Et3N (0.03 mL, 0.23 mmol), and
DMAP (3.0 mg, 0.024 mmol) in THF (3.0 mL) at 0 °C. After
stirring for 1 h, the reaction mixture was diluted with
saturated NaHCO3 solution and extracted with ether, which
was washed with water and brine, dried, and concentrated to
dryness. Chromatography of the residue with hexane-ethyl
acetate (20:1) gave (+)-31 (43.8 mg, 70%) as a colorless oil.
Further elution with hexane-ethyl acetate (2:1) afforded (-)-
32 (17 mg, 20%) as a colorless oil. (+)-5-Episecosyrin 1 (31):
(+)-(2R,3S,4R)-3,4-Bis(ben zyloxy)-2-[[(ter t-bu tylth io)-
ca r bon yl]m eth yl]-2-((Z)-2′-p h en yleth en yl)tetr a h yd r ofu -
r a n (35). According to the procedure described for the
preparation of 27 from 26, compound (+)-34 (230 mg, 0.48
mmol) in ethyl acetate (20 mL) was hydrogenated over Lindlar
catalyst (25 mg) to provide (+)-35 (180 mg, 78%) as a colorless
oil: [R]19
+27.3 (c 0.51, CHCl3); MS m/z 516 (M+, 0.2), 460
D
(27), 352 (21), 203 (35), 131 (63), 91 (95), 57 (100); IR 1680
cm-1 1H NMR δ 7.42-7.14 (m, 15H), 6.55 (d, 1H, J ) 12.7
;
[R]26 +33.6 (c 0.12, CHCl3); MS m/z 272 (M+, 4.9), 230 (9.4),
D
216 (17), 167 (25), 149 (61), 99 (100); IR 3450, 1780, 1735 cm-1
;
Hz), 5.89 (d, 1H, J ) 12.7 Hz), 4.45, 4.38 (AB-q, 2H, J ) 12.2
Hz), 4.40 (s, 2H), 4.15 (d, 1H, J ) 2.0 Hz), 4.00-3.99 (m, 2H),
3.59 (ddd, 1H, J ) 2.0, 2.4, 5.9 Hz), 3.16, 3.12 (AB-q, 2H, J )
1H NMR δ 5.03 (d, 1H, J ) 1.7 Hz), 4.37, 4.32 (AB-q, 2H, J )
10.2 Hz), 4.31 (ddd, 1H, J ) 1.7, 2.6, 5.3 Hz), 4.17 (dd, 1H, J
) 5.3, 10.2 Hz), 3.83 (dd, 1H, J ) 2.6, 10.2 Hz), 2.86, 2.75 (AB-
q, 2H, J ) 18.5 Hz), 2.36 (t, 2H, J ) 7.6 Hz), 1.72-1.55 (m,
2H), 1.42-1.22 (m, 4H), 0.90 (t, 3H, J ) 6.9 Hz); 13C NMR δ
174.59, 173.48, 85.86, 82.97, 76.01, 72.87,72.81, 39.36, 33.98,
31.16, 24.46, 22.19, 13.82; HRMS calcd for C13H20O6 273.1260,
15.6 Hz), 1.42 (s, 9H);
13C NMR δ 197.34, 137.86, 137.04,
133.23, 130.91, 129.31, 128.39, 128.27, 127.80, 127.69, 127.62,
127.57, 127.51, 126.90, 87.76, 85.16, 83.00, 72.06, 71.47, 70.14,
49.71, 47.93, 29.76. Anal. Calcd for C32
7.02. Found: C, 74.24; H, 7.12.
H36O4S: C, 74.39; H,
found 272.1256. Diester (-)-32: [R]25 -15.6 (c 0.12, CHCl3);
(+)-(3R,4S,5R)-3,4-Bis(ben zyloxy)-1,7-d ioxa sp ir o[4.4]-
n on a n -8-on e (36). According to the procedure described for
the preparation of 29 from 27, compound (+)-35 (103 mg, 0.2
mmol) was treated successively with ozone, NaBH4, and DBU
to afford (+)-36 (53.1 mg, 75%) as colorless needles: mp 64.5-
65.5 °C (hexane-ether); [R]23D +34.0 (c 0.22, CHCl3); MS m/z
354 (M+, 0.99), 263 (100), 157 (37), 91 (97), 65 (51); IR 1785
D
MS m/z 370 (M+, 1.7), 314 (8.3), 212 (29), 171 (32), 99 (100),
1
71 (47); IR 1790, 1745 cm-1; H NMR δ 5.32 (d, 1H, J ) 1.5
Hz), 5.15 (ddd, 1H, J ) 1.5, 2.0, 4.9 Hz), 4.33, 4.31 (AB-q, 2H,
J ) 10.7 Hz), 4.28 (dd, 1H, J ) 4.9, 10.7 Hz), 3.86 (dd, 1H, J
) 2.0, 10.7 Hz), 2.80, 2.74 (AB-q, 2H, J ) 17.6 Hz), 2.37 (t,
2H, J ) 7.3 Hz), 2.35 (t, 2H, J ) 7.3 Hz), 1.71-1.55 (m, 4H),
1.42-1.22 (m, 8H), 0.91 (t, 6H, J ) 6.8 Hz); 13C NMR δ 173.96,
172.42, 172.25, 86.34, 79.00, 72.58, 71.66, 39.10, 33.96, 33.86,
31.14, 24.42, 22.19, 13.82. Anal. Calcd for C19H30O7: C, 61.60;
H, 8.16. Found: C, 61.31; H, 8.28.
1
cm-1; H NMR δ 7.43-7.22 (m, 10H), 4.66, 4.46 (AB-q, 2H, J
) 11.9 Hz), 4.54, 4.50 (AB-q, 2H, J ) 9.6 Hz), 4.31, 4.21 (AB-
q, 2H, J ) 10.2 Hz), 4.12 (ddd, 1H, J ) 2.0, 2.3, 4.6 Hz), 4.05
(dd, 1H, J ) 4.6, 9.9 Hz), 3.92 (dd, 1H, J ) 2.3, 9.9 Hz), 3.87
(d, 1H, J ) 2.0 Hz), 2.96, 2.56 (AB-q, 2H, J ) 8.5 Hz); 13C
NMR δ 175.51, 137.63, 137.43, 129.13, 128.73, 128.61, 128.23,
128.14, 87.73, 84.62, 82.12, 76.52, 72.85, 72.29, 71.36, 35.56.
Anal. Calcd for C21H22O5: C, 71.17; H, 6.26. Found: C, 70.97;
H, 6.25.
H exa ca r b on yl-µ-[η4-ter t-b u t yl (-)-(3S,4S,5R)-4,5-b is-
(ben zyloxy)-3,6-d ih yd r oxy-3-(p h en yleth yn yl)h exa n eth -
ioa te]d icoba lt (Co-Co) (33). A solution of (-)-25 (90 mg,
0.17 mmol) in ether (1.5 mL) was added dropwise to a stirred
solution of octacarbonyldicobalt (68.4 mg, 0.2 mmol) in ether
(3.0 mL). The reaction mixture was stirred at rt for 4 h and
then ether was evaporated off. The residue was chromato-
graphed with hexane-ethyl acetate (20:1) to afford 33 (136
mg, 98%) as a deep brown oil: MS (FAB) m/z 819 (M+ + 1,
0.1), 331 (34), 171 (100), 153 (23), 46 (8.5); IR 3400, 2075, 2025,
1995, 1650 cm-1; 1H NMR δ 7.54-7.16 (m, 15H), 5.46 (s, 1H),
4.95, 4.65 (AB-q, 2H, J ) 9.9 Hz), 4.30 (s, 2H), 4.00 (d, 1H, J
) 7.6 Hz), 3.82-3.66 (m, 3H), 3.69, 2.99 (AB-q, 2H, J ) 6.2
Hz), 2.00 (t, 1H, J ) 5.3 Hz), 1.48 (s, 9H); 13C NMR δ 203.04,
199.35, 138.65, 138.40, 137.93, 129.58, 128.99, 128.66, 128.34,
128.21, 127.67, 82.88, 81.12, 79.61, 76.39, 72.22, 62.59, 52.17,
49.44, 29.69. Anal. Calcd for C38H36Co2O11S: C, 55.75; H, 4.43.
Found: C, 55.91; H, 4.47. Specific rotation could not be
determined because demetalation occurred during measure-
ment.
(+)-(2R,3S,4R)-3,4-Bis(ben zyloxy)-2-[[(ter t-bu tylth io)-
car bon yl]m eth yl]-2-(ph en yleth yn yl)tetr ah ydr ofu r an (34).
To a solution of 33 (130 mg, 0.16 mmol) in CH2Cl2 (4.0 mL)
was added BF3‚Et2O (0.1 M CH2Cl2 solution, 1.7 mL, 0.17
mmol) at rt, and the reaction mixture was stirred for 3 h. The
mixture was quenched with water and extracted with CH2-
Cl2. The organic layer was washed with water and brine,
dried, and concentrated to give the cobalt-complexed residue,
which was dissolved in MeOH (5.0 mL). To a solution of
cobalt-complexed 34 and 26 in MeOH was added CAN (351
mg, 0.64 mmol) at 0 °C, and the reaction mixture was stirred
for 25 min at the same temperature. MeOH was evaporated
off and the residue was taken up in ethyl acetate, which was
washed with water, dried, and concentrated to dryness.
Chromatography of the residue with hexane-ether (10:1)
(+)-(3R,4S,5R)-3,4-Dih ydr oxy-1,7-dioxaspir o[4.4]n on an -
8-on e (37). According to the procedure described for the
preparation of 30 from 29, compound (+)-36 (180.5 mg, 0.51
mmol) was hydrogenolyzed over 10% Pd/C catalyst (18 mg)
under hydrogen atmosphere at rt to provide (+)-37 (79.8 mg,
90%) as colorless needels: mp 107-108 °C (hexane-ethyl
acetate); [R]25
+75.3 (c 0.22, MeOH); MS m/z 174 (M+, 0.55),
D
170 (0.3), 156 (15), 116 (100), 74 (82), 56 (68); IR 3350, 3475,
1
1775 cm-1; H NMR δ 4.86 (br s, 2H), 4.42, 4.37 (AB-q, 2H, J
) 10.2 Hz), 4.22-4.09 (m, 1H), 4.15 (dd, 1H, J ) 4.6, 8.9 Hz),
4.00 (d, 1H, J ) 2.0 Hz), 3.79 (dd, 1H, J ) 1.3, 8.9 Hz), 3.06,
2.47 (AB-q, 2H, J ) 18.1 Hz); 13C NMR δ 178.23, 89.83, 80.28,
78.09, 77.95, 74.16, 36.37. Anal. Calcd for C7H10O5: C, 48.28;
H, 5.79. Found: C, 48.22; H, 5.83.
(+)-(3 R ,4 S ,5 R )-4 -(H e x a n o y l o x y )-3 -h y d r o x y -1 ,7 -
d ioxa sp ir o[4.4]n on a n -8-on e (3) (Secosyr in 1) a n d (-)-
(3R,4S,5R)-3,4-Bis(h exan oyloxy)-1,7-dioxaspir o[4.4]n on an -
8-on e (38). According to the procedure described for the
preparation of 31 from 30, compound (+)-37 (50.5 mg, 0.29
mmol) was treated with hexanoic anhydride (0.1 M THF
solution, 2.87 mL, 0.29 mmol), Et3N (0.04 mL, 0.29 mmol), and
DMAP (3.7 mg, 0.03 mmol) in THF (3.0 mL) at 0 °C to give
(+)-secosyrin 1 (3) (55.3 mg, 70%) as a colorless oil along with
(-)-38 (26.8 mg, 25%) as a colorless oil. (+)-Secosyrin 1 (3):
[R]26 +48.2 (c 0.12, CHCl3) [lit.10 [R]D +42.85 (c 1.43, CH2-
D
Cl2)]; MS m/z 272 (M+, 12), 158 (39), 128 (39), 99 (99), 98 (75),
1
71 (100); IR 3500, 1785, 1735 cm-1; H NMR δ 4.96 (d, 1H, J
) 2.0 Hz), 4.45, 4.37 (AB-q, 2H, J ) 10.2 Hz), 4.32 (ddd, 1H,
J ) 2.0, 2.7, 5.3 Hz), 4.13 (dd, 1H, J ) 5.3, 10.2 Hz), 3.86 (dd,
1H, J ) 2.7, 10.2 Hz), 2.78, 2.58 (AB-q, 2H, J ) 17.8 Hz), 2.37